Filing Flows › Clorox (CLX) › Guidance & outlook
Clorox (CLX) guidance and outlook
Clorox (CLX) lowered its guidance on Nov 2, 2026: Gross margin 41.5% for FY2027; Tax rate 23% for FY2027; EPS $5.41–$5.71 for FY2027; EPS $5.70–$6.00 for FY2027. Clorox's 10-Q filed Nov 2, 2026 makes 16 forward-looking statements.
Guidance and outlook
Latest guidance
| Metric | Period | Range | Change |
|---|---|---|---|
| Revenue | FY2027 | +3.5% to +4.5% | new |
| Gross margin | FY2027 | 41.5% | lowered |
| Tax rate | FY2027 | 23% | reaffirmed |
| EPS | FY2027 | $5.41–$5.71 | reaffirmed |
| EPS | FY2027 | $5.70–$6.00 | reaffirmed |
| EPS | FY2027 | +3% to +8% | reaffirmed |
| EPS | FY2027 | $5.41 | reaffirmed |
From the earnings release filed Nov 2, 2026 (8-K on EDGAR).
Forward-looking statements, 10-Q filed Nov 2, 2026
- Though the Company has taken and will continue to take action to mitigate such impacts, the Company anticipates the operating environment will remain volatile and challenging.
- Given the dynamic nature of these conditions, the Company expects continued variability in the operating environment.
- For fiscal year 2027, the Company anticipates the operating environment will remain volatile and challenging as consumers may face greater pressure as continued macroeconomic uncertainty impacts spending.
- The Company will continue to invest in its brands, capabilities and people to deliver consistent, profitable growth over time.
- There would not be an expected material impact to the Company’s liquidity or capital resources if the financial institution or a supplier terminated the SCF arrangement.
- While the Company does not have direct access to information on, or influence over, which invoices a participating supplier elects to sell to the financial institution, the Company expects that the majority of these amounts have been sold to the financial institution.
- Notwithstanding potential unforeseen adverse market conditions and as part of the Company’s regular assessment of its cash needs, the Company believes it will have the funds necessary to support its short- and long-term liquidity and operating needs, including its ability to invest in its brands, capabilities and people to deliver consistent profitable growth over time based on its anticipated ability to generate…
- There were no borrowings under the Revolving Credit Agreements as of both September 30, 2026 and June 30, 2026, and the Company believes that borrowings under the Revolving Credit Agreements will continue to be available for the purposes stated
- The Company was in compliance with all restrictive covenants and limitations in the Revolving Credit Agreements as of September 30, 2026 and anticipates being in compliance with all restrictive covenants for the foreseeable future.
- As of September 30, 2026, the Company had two stock repurchase programs: an open-market purchase program with an authorized aggregate purchase amount of up to $2,000, which has no expiration date, and a program to offset the anticipated impact of dilution related to stock-based awards (the Evergreen Program), which has no authorization limit on the dollar amount and no expiration date.
- As a result of this transaction, various acquisition and integration-related costs related to the acquisition and efforts to integrate the recently acquired business to the Company’s systems and processes were and will be incurred.
- Since these strategic investments, including incremental operating costs, ceased at the end of the investment period, are not expected to recur in the foreseeable future and are not considered representative of the Company's underlying operating performance, the Company's management believes presenting these costs as an adjustment in the non-GAAP results provides additional information to investors about trends…
Clorox's latest quarter
Clorox, Q1 FY27: revenue $1.9B (+33% year over year), operating margin 10.9%, net earnings $170M, operating cash flow $143M. The chart follows the revenue to costs, profit and cash.
Questions
Did Clorox raise or lower its guidance?
Clorox (CLX) lowered its guidance on Nov 2, 2026: Gross margin 41.5% for FY2027; Tax rate 23% for FY2027; EPS $5.41–$5.71 for FY2027; EPS $5.70–$6.00 for FY2027.
What does Clorox expect?
Though the Company has taken and will continue to take action to mitigate such impacts, the Company anticipates the operating environment will remain volatile and challenging. Given the dynamic nature of these conditions, the Company expects continued variability in the operating environment. For fiscal year 2027, the Company anticipates the operating environment will remain volatile and challenging as consumers may face greater pressure as continued macroeconomic uncertainty impacts spending.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.